SPEAKERS
Dr CHARLOTTE BLEASE
Associate Professor of Health Informatics, Uppsala University
Dr Charlotte Blease, originally from Belfast, is a health informaticist, Associate Professor at the Uppsala University, Sweden and Research Affiliate at Digital Psychiatry, Harvard Medical School. Her PhD was in philosophy of science and mind (2008). She has worked in health research for nearly 20 years, with 200 publications, holding academic posts in the US including at Harvard Medical School, in Europe and the UK and is currently Visiting Professor at University of Melbourne. “Dr Bot: Why doctors can fail us and how AI could save lives” was published with Yale University Press in September 2025. She is also co-author of The Nocebo Effect: When Words Make You Sick (Mayo Clinic Press 2024).
Dr MATTHEW BONAM
Vice President, Digital Health, Evinova
Prof TIANXI CAI
Professor of Biomedical Informatics, Harvard Medical School
Tianxi Cai is the John Rock Professor of Population and Translational Data Science at the Harvard T.H. Chan School of Public Health and a Professor of Biomedical Informatics at Harvard Medical School, where she is the founding Director of the Translational Data Science Center for a Learning Health System (CELEHS). She is a Fellow of the American Statistical Association and the Institute of Mathematical Statistics, and a Co-Editor of the Journal of the American Statistical Association. Her research focuses on transforming large, multi-institutional electronic health record data into trustworthy, clinically actionable evidence by developing statistical and AI methods that generalize across healthcare systems, integrate clinical and genomic data, and support more precise and equitable care. Her group also develops and disseminates open-source tools that standardize EHR data, automate information extraction and outcome curation from clinical notes using natural language processing and large language models, and enable reproducible predictive modeling workflows for cross-site deployment.
Prof TIM FRIEDE
Director of the Institute for Medical Statistics, University Medical Center Göttingen
Tim Friede is Professor of Biostatistics at the University Medical Center Göttingen (Germany) where he heads up the Department of Medical Statistics. He graduated in Mathematics (Dipl.-Math.) from the University of Karlsruhe (Germany) and obtained a PhD (Dr.sc.hum.) from the Faculty of Medicine at the University of Heidelberg (Germany). Tim Friede is Associate Editor of Statistics in Medicine and Biometrical Journal as well as European Journal of Heart Failure and ESC Heart Failure. He has served the International Biometric Society (IBS) in various capacities including a term as president of the German Region. He currently chairs the Representative Council of the IBS. His methodological research interests are in clinical biostatistics including clinical trial designs (especially adaptive designs) and systematic reviews / meta-analyses as well as applications of AI/ML. Tim Friede published more than 450 articles on methodology and applications of statistics in peer-reviewed journals.
Prof GLENDA GRAY
Chief Scientific Officer, South African Medical Research Council
Glenda E. Gray is the Director of the Infectious Disease and Oncology Research Institute (IDORI) at Wits. She was the first female President and CEO of the SAMRC, where she led the scientific strategy and prioritization of medical research in South Africa. She is the Chair of the Board of the Global Antibiotic R&D Partnership and serves as a board member of the National Research Foundation, the South African Health Products Regulatory Authority. She is a member of the South African Academy of Science, the African Academy of Science, the World Academy of Science and the US National Academy of Medicine. She received South Africa’s highest honour, the Order of Mapungubwe the Nelson Mandela Health and Human Rights Award for her pioneering research in preventing paediatric HIV. She has been named as one of Time’s 100 Most Influential People in the World and Forbes top 50 women in Africa in recognition of her research in HIV. She is a NRF A rated scientist and has published over 450 scientific articles.
Dr GUSTAVO MONNERAT
Deputy Editor, The Lancet Regional Health – Americas
Gustavo Monnerat holds a PhD in Physiology, a Postdoctoral Fellowship in Omics for Clinical Biomarkers, and an MBA in Management. He is a member of The Lancet’s AI Working Group and has a strong interest in the intersection of artificial intelligence, digital health, and global health. His work focuses on scientific communication, innovation in healthcare, and the integration of emerging technologies into clinical and public health practice.
Dr VASEE MOORTHY
Senior Advisor, Science and Strategy, WHO Science for Health Department
Vasee Moorthy is a senior advisor in the Science for Health Department, in the Science Division at WHO. He leads a global programme on strengthening the clinical trial environment. At the direction of a 2022 World Health Assembly Resolution, the programme has developed WHO’s guidance on best practices for clinical trials (2024) that focuses on inclusion, engagement, trial design principles and recommendations to national authorities for how they can streamline clinical trial approval processes, embed research into their health systems and improve the overall clinical trial environment for patients and researchers in their country. He convenes the WHO Global Clinical Trial Forum (GCTF), a network of 35 institutions that have committed to support quality and efficiency improvements in clinical trials including the adoption of digital tools.
Dr JUSTINE ROCHON
Head of R&D Data and Quantitative Sciences, SVP Takeda
Justine Rochon is a psychologist and biostatistician with a Doctoral Degree in Medical Sciences from the University of Heidelberg and an Executive Certificate in Management and Leadership from MIT Sloan. Justine led the transformation of a global data science organization at a leading pharmaceutical company into an agile, data-driven powerhouse that redefined innovation culture and delivered outstanding results. A recognized catalyst for change, she has contributed to cross-industry collaborations, including a strategic alliance with major pharmaceutical partners and the CCAIM, a premier institute for AI-driven medicine in Cambridge, UK. She has held leadership roles at EFSPI and ASA-BIOP, co-founded the DISRUPT–DS (Data Science) Roundtable, teaches at universities, and advises academic institutions and startups as a board member. Co-author of the Charter for Data Science in Pharmaceutical R&D and the Manifesto for AI-Driven Clinical Trials, she champions the transformative though realistic use of AI in drug development. In 2025, Reuters Events recognized her among the Top 10 Trailblazing Women in Pharma.
Prof RODOLPHE THIEBAUT
Director, Bordeaux Population Health, University of Bordeaux
Rodolphe Thiebaut is professor of Public Health and Biostatistics at the University of Bordeaux and adjunct professor at McGill University (Department of Epidemiology, Biostatistics and Occupational Health). He leads the Inserm U1219 Bordeaux Population Health research centre, in which he has created the research group SISTM (Statistics in Systems Biology and Translational Medicine) devoted to data science in immunology. This group has been recognized as an INRIA project team since January 2015 (http://www.inria.fr/equipes/sistm).
He leads the Department of Medical Information of the Bordeaux Hospital in charge of the methodological support of the clinical research at the hospital as well as the organisation and the analysis of medical information including the Clinical Data Warehouse. Since 2018, he has led the Graduate’s program Digital Public Health that includes a Master in Public Health Data Science, a dual degree program with McGill University (https://www.isped.u-bordeaux.fr/Graduate-Programs/Digital-Public-Health/About-us).
Dr LAURA TROTTA
Vice President of Research Operations and Statistical Innovation, CluePoints
Laura Trotta joined CluePoints in 2015 and currently serves as Vice President of Research Operations and Statistical Innovation. In this role, she leads a team of research scientists focused on developing advanced algorithms to assess the quality of clinical trial data. She holds a Master’s degree in Biomedical Engineering and a PhD in Applied Mathematics from the University of Liège, Belgium.
